Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Busfield

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|March 20, 2002
Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survivalQunrui Ye, Christopher C Fraser, Wei Gao, et al.
Genomics|June 22, 2000
Identification and gene organization of three novel members of the IL-1 family on human chromosome 2S J Busfield, C A Comrack, G Yu, et al.
Blood|December 24, 2013
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cellsEva Nievergall, Hayley S Ramshaw, Agnes S M Yong, et al.
Molecular and Cellular Biology|July 1, 1997
Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampusS J Busfield, D A Michnick, T W Chickering, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Cloning, expression, and function of BLAME, a novel member of the CD2 familyG A Kingsbury, L A Feeney, Y Nong, et al.
Haematologica|July 2, 2015
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient miceErwin M Lee, Dean Yee, Samantha J Busfield, et al.
Cell Stem Cell|July 3, 2009
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cellsLiqing Jin, Erwin M Lee, Hayley S Ramshaw, et al.
Leukemia|April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCCS J Busfield, M Biondo, M Wong, et al.
Leukemia|February 23, 2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyE Nievergall, J Reynolds, C H Kok, et al.
Oncogene|May 23, 2003
Differential regulation of SOCS genes in normal and transformed erythroid cellsMohinder K Sarna, Evan Ingley, Samantha J Busfield, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|March 20, 2002
Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survivalQunrui Ye, Christopher C Fraser, Wei Gao, et al.
Genomics|June 22, 2000
Identification and gene organization of three novel members of the IL-1 family on human chromosome 2S J Busfield, C A Comrack, G Yu, et al.
Blood|December 24, 2013
Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cellsEva Nievergall, Hayley S Ramshaw, Agnes S M Yong, et al.
Molecular and Cellular Biology|July 1, 1997
Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampusS J Busfield, D A Michnick, T W Chickering, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Cloning, expression, and function of BLAME, a novel member of the CD2 familyG A Kingsbury, L A Feeney, Y Nong, et al.
Haematologica|July 2, 2015
Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient miceErwin M Lee, Dean Yee, Samantha J Busfield, et al.
Cell Stem Cell|July 3, 2009
Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cellsLiqing Jin, Erwin M Lee, Hayley S Ramshaw, et al.
Leukemia|April 8, 2014
Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCCS J Busfield, M Biondo, M Wong, et al.
Leukemia|February 23, 2016
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapyE Nievergall, J Reynolds, C H Kok, et al.
Oncogene|May 23, 2003
Differential regulation of SOCS genes in normal and transformed erythroid cellsMohinder K Sarna, Evan Ingley, Samantha J Busfield, et al.
Pageof 4